ArticleBMC medical informatics and decision making2025
Treatment decision support for esophageal cancer based on PET/CT data using deep learning.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning applications in the detection and treatment of esophageal cancer.Discover oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMaking precise treatment decisions in esophageal cancer is essential for enhancing patient outcomes and avoiding overtreatment. Traditional approaches relying on special features or shallow learning models often fail to capture the complex, multi-scale patterns embedded in PET/CT imaging data. Recent advances in deep learning provide an opportunity to build more robust, data-driven systems for predictive modeling in oncology.
methodsWe propose a novel deep learning model that integrates convolutional and transformer-based components based on PET/CT data to support treatment decisions for esophageal cancer. The architecture introduces a Convolutional Feature Extractor with split-based residual blocks for efficient local feature capture, a Multi-scale Pooling module for spatial context aggregation, and an Multilayer Perceptron block for predicting. The model was evaluated using several performance metrics such as AUCROC, F1 score, Balanced Accuracy and benchmarked against state-of-the-art convolutional and transformer backbones such as ConvNeXt and Vision Transformer.
resultsThe proposed model achieved superior performance across all evaluation metrics, including an AUCROC of 0.9935 and a Balanced Accuracy of 0.9630, outperforming existing models. These results validate the effectiveness of combining local-global representation learning through custom-designed modules. In addition, we conducted ablation studies to further demonstrate the individual contributions and effectiveness of each component within the proposed architecture. By systematically removing or replacing specific modules such as the Convolutional Feature Extractor and Multi-scale Pooling, we observed consistent performance degradation, which highlights the necessity and complementary roles of these components in achieving optimal predictive accuracy.
conclusionsThis study presents a novel hybrid deep learning architecture that enhances treatment decision support for esophageal cancer by leveraging multi-scale spatial encoding. The empirical evidence demonstrates that tailored architectural innovations significantly improve predictive accuracy over existing methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.